Q4 2025 Holdings
Filed 2026-02-13 | 17 holdings | $555.0M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2026-03-18) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Protagonist Therapeutics Inc.(PTGX) | COM | 74366E102 | $213.9M | 2,449,183 | 38.5% |
| Nanobiotix S.A.(NBTX) | SPONSORED ADS | 63009J107 | $130.0M | 5,623,816 | 23.4% |
| Rapport Therapeutics, Inc.(RAPP) | COM | 75383L102 | $54.1M | 1,784,517 | 9.8% |
| MeiraGTx Holdings plc(MGTX) | COM | G59665102 | $52.8M | 6,641,064 | 9.5% |
| CVRx, Inc.(CVRX) | COM | 126638105 | $28.6M | 4,024,861 | 5.1% |
| Contineum Therapeutics Inc.(CTNM) | CL A | 21217B100 | $22.6M | 1,979,173 | 4.1% |
| Legend Biotech Corporation(LEGN) | SPONSORED ADS | 52490G102 | $17.7M | 814,586 | 3.2% |
| Xencor, Inc.(XNCR) | COM | 98401F105 | $11.5M | 748,062 | 2.1% |
| Procept BioRobotics Corporation(PRCT) | COM | 74276L105 | $11.3M | 357,939 | 2.0% |
| Fate Therapeutics, Inc.(FATE) | COM | 31189P102 | $3.3M | 3,379,064 | 0.6% |
| Neumora Therapeutics, Inc.(NMRA) | COM | 640979100 | $3.3M | 1,849,445 | 0.6% |
| Rallybio Corporation | COM | 75120L100 | $2.5M | 3,636,363 | 0.4% |
| Lyell Immunopharma, Inc.(LYEL)A | COM NEW | 55083R203 | $1.7M | 54,887 | 0.3% |
| Vor Biopharma, Inc.(VOR) | COM NEW | 929033207 | $702.8K | 53,732 | 0.1% |
| Nano-X Imaging Ltd.(NNOX) | ORD SHS | M70700105 | $444.8K | 158,852 | 0.1% |
| Standard BioTools, Inc.(LAB) | COM | 34385P108 | $399.3K | 311,967 | 0.1% |
| Adicet Bio, Inc.(ACET) | COM NEW | 007002207 | $191.8K | 22,779 | 0.0% |